Table 2.

Outcomes of assessable patients with pancreatic cancer according to protein expression

Variable	Overall survival			Disease-free survival
	HR	95 % CI	P	HR	95 % CI	P
LC3
Low (n = 50)	1	0.087–0.589	0.200	1	0.251–1.387	0.226
High (n = 43)	0.227			0.590
ALDH1
Low (n = 51)	1	0.516–3.684	0.522	1	0.315–1.481	0.335
High (n = 42)	1.378			0.684
LC3/ALDH1
Low (n = 54)	1	1.622–13.739	0.004	1	2.535–17.170	0.000
High (n = 39)	4.721			6.597
OPN
Low (n = 58)	1	0.233–2.430	0.634	1	0.442–4.234	0.587
High (n = 35)	0.752			1.368
OPN/LC3/ALDH1
Low (n = 42)	1	Reference		1	Reference
Moderate (n = 28)	1.770	0.846–3.704	0.130	1.351	0.773–2.362	0.291
High (n = 23)	2.385	1.129–5.038	0.023	2.245	1.183–4.259	0.013
OPN/CD44/CD133
Low (n = 39)	1	Reference		1	Reference
Moderate (n = 42)	1.929	0.897–4.146	0.093	1.639	0.889–3.021	0.113
High (n = 12)	4.527	1.403–14.604	0.011	4.140	1.672–10.254	0.002

The bold value indicates P < 0.05